| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lucid Diagnostics Inc. (LUCD) has 4 insiders with recent SEC Form 4 filings, including 5 buys and 9 sells. LUCD is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 1.81M | $1.74M | - | |
| COO | 1.45M | $1.39M | - | |
| Dir | 665.4K | $639.2K | - | |
| Dir | 215.0K | $206.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | Matheis Dennis | Director | Buy | 100,000 | $1.02 | $101,840.00 | +17.7% | +1.9% | - | |
| May 22, 2025 | Matheis Dennis | Director | Buy | 350,000 | $1.31 | $457,606.58 | +69.5% | -22.6% | - | |
| Sep 26, 2023 | Lapidus Stanley74 | Director | Sell | 29,947 | $1.45 | $43,459.15 | -6.0% | -5.4% | -48.7% | |
| Sep 21, 2023 | Lapidus Stanley74 | Director | Sell | 3,917 | $1.45 | $5,674.53 | -1.0% | -4.9% | -42.7% | |
| Sep 20, 2022 | Lapidus Stanley74 | Director | Sell | 33,864 | $1.70 | $57,682.70 | -10.5% | -8.1% | -16.2% | |
| Oct 18, 2021 | Pavmed Inc. | 10% Owner | Buy | 571,428 | $14.00 | $7,999,992.00 | +2.1% | -56.7% | -80.2% |